SECUREMEDS: BLOCKCHAIN PROTECTION FOR DRUG CHANNELS
RAEHA SYED
Department of Information Science and Engineering Atria Institute of Technology Bangalore, Karnataka, India raeha18@gmail.com
RAKSHITHA B S
Department of Information Science and Engineering Atria Institute of Technology Bangalore, Karnataka, India rakshithabs2002@gmail.com
MEENATCHI R
Department of Information Science and Engineering Atria Institute of Technology Bangalore, Karnataka, India
Meenatchi.r@atria.edu
RICHA H S
Department of Information Science and Engineering Atria Institute of Technology
Bangalore, Karnataka, India richasalian279@gmail.com
Abstract—. The World Health Organisation (WHO) highlights the global threat of medicine counterfeiting, particularly in low- and middle-income countries where 10% of drugs may be counterfeit or of inferior quality, hence creating serious health hazards to the general public. Because there are shortages of necessary medications during illness outbreaks, this problem gets worse. Fighting this issue requires increased public awareness campaigns, improved pharmaceutical accessibility, and international cooperation Our goal is to create a strong framework for monitoring pharmaceuticals at every stage of the supply chain—manufacturers, distributors, retailers, and government agencies such as the FDA. A tamper-proof and easily traceable supply chain can be ensured by implementing blockchain technology and using transparent contractual arrangements. Furthermore, cutting-edge techniques like smart contracts made possible by Ganache and Ethereum improve supply chain integrity. Verification codes are sent via email to strengthen authentication processes and provide an additional degree of protection. Moreover, batch number hashing is secured by SHA encryption, guaranteeing complete protection during the distribution process. Global pharmaceutical safety and efficacy are guaranteed by this all-encompassing strategy.. .
Keywords— Pharmaceutical Supply Chain Counterfeit Medications Blockchain Technology FDA (Food and Drug Administration).
